145 related articles for article (PubMed ID: 18348668)
1. [Costs of a cytostatic drug preparation unit in a hospital in Mexico].
Martínez Rodríguez OA; Rivas Bocanegra RE; Ascencio-Pérez IS; Zapata Sánchez LA
Farm Hosp; 2007; 31(6):375-8. PubMed ID: 18348668
[TBL] [Abstract][Full Text] [Related]
2. [The role of the cytostatic drugs unit in rationalization of hospital drugs management--the case study and the analysis of drug utilization].
Zuziak S; Topór-Madry R; Pilc A; Bochenek T
Pol Merkur Lekarski; 2014 Jul; 37(217):43-8. PubMed ID: 25154199
[TBL] [Abstract][Full Text] [Related]
3. Reusing cytostatics in a centralised pharmacy preparation unit.
Ramos Linares S; Merino Alonso J; Román González N; Tévar Alfonso E; Díaz Ruíz P; Gorchs Molist M
Farm Hosp; 2011; 35(2):70-4. PubMed ID: 20869287
[TBL] [Abstract][Full Text] [Related]
4. [Economical assessment of intravenous mixture centralization].
Martínez-Tutor MJ
Farm Hosp; 2006; 30(6):351-8. PubMed ID: 17298192
[TBL] [Abstract][Full Text] [Related]
5. Economic assessment of aseptic compounding rooms in hospital pharmacies in five European countries.
Dekyndt B; Décaudin B; Lannoy D; Odou P
J Oncol Pharm Pract; 2015 Apr; 21(2):102-10. PubMed ID: 24519187
[TBL] [Abstract][Full Text] [Related]
6. [Cost of functioning of a centralised pharmaceutical unit: evaluation of mean costs of chemotherapy preparations according to the level of production of the unit].
Galy G; Bauler S; Buchi M; Pirot F; Pivot C
Bull Cancer; 2011 Oct; 98(10):1153-63. PubMed ID: 22001702
[TBL] [Abstract][Full Text] [Related]
7. Variable cost per dose of preparing and administering small-volume cephalosporin admixtures. Veterans Administration Pharmacy Service Study Group.
Am J Hosp Pharm; 1984 Dec; 41(12):2624-34. PubMed ID: 6517086
[TBL] [Abstract][Full Text] [Related]
8. Justification of a pharmacy intravenous admixture service in an Australian hospital.
Plumridge RJ; Maher M
Am J Hosp Pharm; 1993 Mar; 50(3):463-6. PubMed ID: 8442462
[TBL] [Abstract][Full Text] [Related]
9. Impact of the implementation of vasoactive drug protocols on costs in the treatment of critically ill patients.
Cuesta-López I; Sánchez-Cuervo M; Candela-Toha Á; Benedí-González J; Bermejo-Vicedo T
Farm Hosp; 2018 Mar; 42(2):62-67. PubMed ID: 29501057
[TBL] [Abstract][Full Text] [Related]
10. Personnel costs and preparation time in a centralized intravenous admixture program.
Ryan DM; Daniels CE; Somani SM
Am J Hosp Pharm; 1986 May; 43(5):1222-5. PubMed ID: 3087164
[TBL] [Abstract][Full Text] [Related]
11. Cost analysis of mixing clindamycin and aminoglycosides.
Abel SR; Olson SM
Am J Hosp Pharm; 1987 Jun; 44(6):1385-7. PubMed ID: 3618617
[TBL] [Abstract][Full Text] [Related]
12. Relative costs of anesthesiologist prepared, hospital pharmacy prepared and outsourced anesthesia drugs.
Jelacic S; Craddick K; Nair BG; Bounthavong M; Yeung K; Kusulos D; Knutson JA; Somani S; Bowdle A
J Clin Anesth; 2017 Feb; 36():178-183. PubMed ID: 28183562
[TBL] [Abstract][Full Text] [Related]
13. Preparation times and costs for various solutions used for continuous renal replacement therapy.
Shaw AR; Chaijamorn W; Clark JS; Mueller BA
Am J Health Syst Pharm; 2018 Jun; 75(11):808-815. PubMed ID: 29802114
[TBL] [Abstract][Full Text] [Related]
14. Microcosting method for small-volume injectables.
Hatoum HT; Witte KW; Biedron GT; Hutchinson RA
Am J Hosp Pharm; 1986 Feb; 43(2):348-54. PubMed ID: 3953595
[TBL] [Abstract][Full Text] [Related]
15. Effect of requiring advance approval of chemotherapy on number and cost of ungiven doses.
Berhoune M; Aboudagga H; Jacob A; Grandhaye JP; Dayot C; Prognon P; Bonan B
Am J Health Syst Pharm; 2011 Apr; 68(7):557-8. PubMed ID: 21411796
[No Abstract] [Full Text] [Related]
16. Documentation of chemotherapy infusion preparation costs in academic- and community-based oncology practices.
Brixner DI; Oderda GM; Nickman NA; Beveridge R; Jorgenson JA
J Natl Compr Canc Netw; 2006 Mar; 4(3):197-208. PubMed ID: 16507268
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacoeconomic aspects of oral cytostatic agents].
Poquet Jornet JE; Carrera-Hueso FJ; Gasent Blesa JM; Peris Godoy M
Farm Hosp; 2011 May; 35 Suppl 2():25-31. PubMed ID: 22445506
[TBL] [Abstract][Full Text] [Related]
18. Cost analysis of using premixed frozen versus hospital-reconstituted cefazolin sodium injection.
Havlovic DA; Ivey MF; Grotzinger RP
Am J Hosp Pharm; 1987 Apr; 44(4):783-7. PubMed ID: 3578311
[TBL] [Abstract][Full Text] [Related]
19. [Financial assessment of device for the preparation of intravenous mixtures in hospital pharmacy].
Casado Collado A; Luengo Pascual L; Herdman M; Bonafont Pujol X; Clemente Bautista S; Jódar Masanés R; Napal Lecumberri V; Serrano Padilla G
Farm Hosp; 2004; 28(4):243-50. PubMed ID: 15369434
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness study of closed system transfer devices for the preparation of antineoplastic agents.
Calzado-Gómez G; Nazco-Casariego GJ; Viña-Romero MM; Gutiérrez-Nicolás F
Farm Hosp; 2017 Sep; 41(5):575-582. PubMed ID: 28847246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
